Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ovarian cancer screening.

Farhad Alexander-Sefre1, Usha Menon, Ian J Jacobs

  • 1Department of Gynaecological Oncology, St Bartholomew's and the Royal London Medical and Dental School, London EC1A 7BE.

Hospital Medicine (London, England : 1998)
|May 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS.

EBioMedicine·2025
Same author

Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.

Contemporary clinical trials·2024
Same author

A Qualitative Study Exploring Barriers to Colorectal Cancer Screening Among Firefighters.

Journal of occupational and environmental medicine·2024
Same author

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

medRxiv : the preprint server for health sciences·2024
Same author

Trials Methodology Research: what is it and why should India invest in it?

The Lancet regional health. Southeast Asia·2024
Same author

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

medRxiv : the preprint server for health sciences·2024

Ovarian cancer screening using serum CA125 and transvaginal ultrasonography may improve survival. However, larger trials are needed to confirm if this impacts overall mortality before recommending routine screening.

Area of Science:

  • Gynecology
  • Oncology
  • Medical Screening

Background:

  • Ovarian cancer is a significant cause of cancer mortality in women.
  • Current screening methods include serum CA125 and transvaginal ultrasonography.
  • Previous studies suggest potential survival benefits from multimodal screening.

Purpose of the Study:

  • To evaluate the effectiveness of multimodal screening for ovarian cancer.
  • To determine if current screening strategies impact overall mortality rates.
  • To assess the need for further large-scale randomized trials.

Main Methods:

  • Review of existing studies on ovarian cancer screening.
  • Analysis of survival data from multimodal screening interventions.
  • Assessment of CA125 and transvaginal ultrasonography efficacy.

Related Experiment Videos

Main Results:

  • Multimodal screening with CA125 and transvaginal ultrasonography shows promise in improving survival.
  • The impact of these screening methods on mortality requires further investigation.
  • Current evidence does not support routine screening implementation.

Conclusions:

  • While promising for survival, ovarian cancer screening requires more robust mortality data.
  • Larger randomized trials are essential to validate the benefits of screening.
  • Routine screening for ovarian cancer is not yet justified based on available evidence.